Physician profile
Alexa M Paley
NPI 1942852199
$7,997.18
in general payments reported to CMS, 2019-2025
37 companies · $2,044 in 2025
The $2,044 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $717 · 2022: $550 · 2023: $1,325 · 2024: $3,362 · 2025: $2,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,016 · Travel and Lodging: $1,555 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,015.84 |
| Travel and Lodging | $1,554.89 |
| Education | $159.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,864.55 | 2021-2025 | Indigo System, Penumbra System, Smart Coil |
| W. L. Gore & Associates, INC. | $939.77 | 2021-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Acuseal Vascular Graft, Gore Tag Conformable Thoracic Endoprosthesis |
| Silk Road Medical, INC. | $801.96 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Bard Peripheral Vascular, INC. | $438.50 | 2021-2024 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon |
| Abbvie INC. | $347.17 | 2025 | |
| Angiodynamics, INC. | $276.26 | 2022-2023 | Auryon Laser System 100-120 Vac |
| Janssen Biotech, INC. | $263.97 | 2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $226.66 | 2025 | |
| Shockwave Medical, INC | $175.95 | 2022 | |
| Genzyme Corporation | $172.11 | 2025 | |
| Sun Pharmaceutical Industries INC. | $159.26 | 2025 | |
| Lilly USA, LLC | $149.71 | 2025 | Taltz, Ebglyss |
| Endologix LLC | $134.23 | 2024 | |
| Ucb, INC. | $103.49 | 2025 | Bimzelx |
| Incyte Corporation | $87.12 | 2025 | Opzelura |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $86.54 | 2025 | Otezla |
| Integra Lifesciences Corporation | $65.61 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Lemaitre Vascular, INC. | $63.36 | 2021 | |
| Pfizer INC. | $60.97 | 2025 | |
| Galderma Laboratories, L.P. | $58.62 | 2025 | Nemluvio |
| Abbott Laboratories | $57.81 | 2025 | Esprit, Femostop |
| Regeneron Healthcare Solutions, INC. | $52.47 | 2025 | Dupixent |
| Bolton Medical INC | $50.89 | 2024 | Treo Abdominal Stent-Graft System |
| Edwards Lifesciences Corporation | $49.53 | 2024 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $36.79 | 2022-2025 | Sotyktu |
| Smith+Nephew, INC. | $35.65 | 2023 | Renasys Go V2 Home, Pico |
| Tactile Systems Technology INC | $34.03 | 2025 | Nimbl, Flexitouch Plus |
| Botanix Sb INC | $31.82 | 2025 | Sofdra |
| Kci USA, INC. | $27.54 | 2023 | Activ.A.C. |
| Medtronic, INC. | $23.98 | 2021 | |
| Convatec INC. | $22.18 | 2024 | |
| Boston Scientific Corporation | $22.05 | 2024 | Ekosonic |
| Leo Pharma INC. | $21.93 | 2025 | Anzupgo |
| Solventum Corporation | $16.25 | 2025 | Activ.A.C. |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.54 | 2025 | Spevigo |
| Cardiva Medical, INC. | $12.86 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexa Paley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.